Publication date: Available online 29 December 2016
Source:Clinical Biochemistry
Author(s): Thomas Boehm, Sophie Pils, Elisabeth Gludovacz, Helen Szoelloesi, Karin Petroczi, Otto Majdic, Andrea Quaroni, Nicole Borth, Peter Valent, Bernd Jilma
ObjectivesDiamine oxidase (DAO) is essential for extracellular degradation of histamine. For decades activity assays with inherent limitations were used to quantify the relative amounts of DAO. No reference DAO standard is available. Absolute DAO amounts cannot be determined. Controversy exists, whether DAO is circulating or not in non-pregnant individuals. The role of DAO as biomarker in various diseases is ambiguous. It is not clear, whether precise quantification of human DAO antigen using commercially available enzyme-linked immunosorbent assays (ELISAs) is possible. The objective was to develop a precise and robust ELISA to quantify DAO in various biological fluids.Design and methodsA research prototype ELISA was established using a mouse monoclonal antibody for capturing and a polyclonal rabbit serum IgG fraction for the detection of human DAO. The limit of blank (LoB), limit of detection (LoD) and estimated limit of quantification (eLoQ) and normal DAO concentrations in serum and plasma were determined.ResultsThe LoB, LoD and eLoQ derived from 42 standard curves are 0.27, 0.48 and 0.7ng/mL respectively. The detection range using the LoD as the lower and the highest DAO standard as the upper boundary is 0.5 to 450ng/mL. Serum and plasma mean/median concentrations are between 0.5 and 1.5ng/mL in healthy volunteers (n=58) and mastocytosis patients (n=19) and plateau at approximately 145ng/mL (n=16) during pregnancy. Accurate quantification was not influenced by heparin (DAO is a heparin-binding protein), lipaemic or hemolytic serum. The measured DAO antigen concentrations are in close agreement with published enzymatic activity data using radioactive putrescine as substrate.ConclusionsThis research prototype ELISA is able to reliably and accurately quantify human DAO in different biological fluids. The potential of DAO as biomarker in various diseases can be evaluated.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2iCHgoO
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract T cell immunoglobulin and mucin domain 3 (Tim-3) is a critical regulatory molecule found on activated Th1 cells, exhausted CD8 + ...
-
International Journal of Engineering Research and Applications (IJERA) is an open access online peer reviewed international journal that pub...
-
CFS, also known as ME, may be caused by the body switching from fully breaking down carbohydrates to using other energy sources, bringing o...
-
Study of Sharp Corner Cutting In Wire EDM Thesis submitted in accordance with The test specimens have been cut by using different wire-cut E...
-
Visit this site dedicated to Valentine from 100 Valentine Poems for your special person. Famous Valentine Poems from the Worlds greatest Poe...
-
You could soon get an even more immersive VR experience thanks to the Ambiotherm plug in, which exposes you to the elements of your virtual...
-
Planta Med DOI: 10.1055/s-0043-106050 Glucose homeostasis is maintained by antagonistic hormones such as insulin and glucagon as well as ...
-
Cancerous tumours are voracious. Once they have consumed all the oxygen and nutrients in the original tumour site, the cancer cells travel t...
-
Publication date: 15 February 2017 Source: Experimental Cell Research, Volume 351, Issue 2 from #AlexandrosSfakianakis via Alexandros...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου